Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase EARLY_PHASE1 2Phase 1 2Phase NA 1Phase 4 1

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Breast 1

Conditions

Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1

Interventions

Magnetic Resonance Spectroscopy 11Oxaliplatin 9Fluorouracil 9Leucovorin 7Irinotecan 7Gemcitabine 7Nivolumab 6Biopsy 6Bevacizumab 6pembrolizumab 5lenvatinib 5Specimen Handling 5Radiosurgery 5Cisplatin 5Capecitabine 5X-Rays 4Radiation 4Proflavine 4Oncolytic Virotherapy 4Cyclophosphamide 4Albumin-Bound Paclitaxel 4130-nm albumin-bound paclitaxel 4sodium thiosulfate 3gallium 68 PSMA-11 3folfirinox 3Surgical Procedures, Operative 3Paclitaxel 3Omeprazole 3Ketamine 3Immune Checkpoint Inhibitors 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Losartan × Gastrointestinal × Clear all
NCT05365893 2026-05-22

PHL Treatment in Pancreatic Cancer

Fox Chase Cancer Center

Phase EARLY_PHASE1 Active not recruiting
20 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT01276613 2019-05-02

Tissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the Pancreas

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Terminated
18 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡